Mutations in NR5A1 Associated with Ovarian Insufficiency

Overview

Journal N Engl J Med

Specialty General Medicine

Date 2009 Feb 28

PMID 19246354

Citations 129

Authors

Diana Lourenco

Raja Brauner

Lin Lin

Arantzazu De Perdigo

Georges Weryha

Mihaela Muresan

Radia Boudjenah

Gil Guerra-Junior

Andrea T Maciel-Guerra

John C Achermann

Ken McElreavey

Anu Bashamboo

Affiliations

Soon will be listed here.

Abstract

Background: The genetic causes of nonsyndromic ovarian insufficiency are largely unknown. A nuclear receptor, NR5A1 (also called steroidogenic factor 1), is a key transcriptional regulator of genes involved in the hypothalamic-pituitary-steroidogenic axis. Mutation of NR5A1 causes 46,XY disorders of sex development, with or without adrenal failure, but growing experimental evidence from studies in mice suggests a key role for this factor in ovarian development and function as well.

Methods: To test the hypothesis that mutations in NR5A1 cause disorders of ovarian development and function, we sequenced NR5A1 in four families with histories of both 46,XY disorders of sex development and 46,XX primary ovarian insufficiency and in 25 subjects with sporadic ovarian insufficiency. None of the affected subjects had clinical signs of adrenal insufficiency.

Results: Members of each of the four families and 2 of the 25 subjects with isolated ovarian insufficiency carried mutations in the NR5A1 gene. In-frame deletions and frameshift and missense mutations were detected. Functional studies indicated that these mutations substantially impaired NR5A1 transactivational activity. Mutations were associated with a range of ovarian anomalies, including 46,XX gonadal dysgenesis and 46,XX primary ovarian insufficiency. We did not observe these mutations in more than 700 control alleles.

Conclusions: NR5A1 mutations are associated with 46,XX primary ovarian insufficiency and 46,XY disorders of sex development.

Citing Articles

Population-Based Study of Rare Coding Variants in /SF-1.

Kouri C, Jia R, Kentistou K, Gardner E, Perry J, Fluck C J Endocr Soc. 2024; 8(12):bvae178.

PMID: 39479520 PMC: 11521259. DOI: 10.1210/jendso/bvae178.

Evidence for NR2F2/COUP-TFII involvement in human testis development.

Wankanit S, Zidoune H, Bignon-Topalovic J, Schlick L, Houzelstein D, Fusee L Sci Rep. 2024; 14(1):17869.

PMID: 39090159 PMC: 11294483. DOI: 10.1038/s41598-024-68860-3.

46,XX Differences of Sex Development outside congenital adrenal hyperplasia: pathogenesis, clinical aspects, puberty, sex hormone replacement therapy and fertility outcomes.

Stancampiano M, Meroni S, Bucolo C, Russo G Front Endocrinol (Lausanne). 2024; 15:1402579.

PMID: 38841305 PMC: 11150773. DOI: 10.3389/fendo.2024.1402579.

Role of Gene Mutations in Disorders of Sex Development: Molecular and Clinical Features.

Luppino G, Wasniewska M, Coco R, Pepe G, Morabito L, Li Pomi A Curr Issues Mol Biol. 2024; 46(5):4519-4532.

PMID: 38785542 PMC: 11119465. DOI: 10.3390/cimb46050274.

The landscape of genetic variations in non-syndromic primary ovarian insufficiency in the MENA region: a systematic review.

Allouch A, Al-Barazenji T, Al-Shafai M, Abdallah A Front Endocrinol (Lausanne). 2024; 14:1289333.

PMID: 38737775 PMC: 11082268. DOI: 10.3389/fendo.2023.1289333.

References

Sugawara T, Kiriakidou M, McAllister J, Kallen C, Strauss 3rd J . Multiple steroidogenic factor 1 binding elements in the human steroidogenic acute regulatory protein gene 5'-flanking region are required for maximal promoter activity and cyclic AMP responsiveness. Biochemistry. 1997; 36(23):7249-55. DOI: 10.1021/bi9628984. View

Qin Y, Choi Y, Zhao H, Simpson J, Chen Z, Rajkovic A . NOBOX homeobox mutation causes premature ovarian failure. Am J Hum Genet. 2007; 81(3):576-81. PMC: 1950834. DOI: 10.1086/519496. View

Zhao H, Li Z, Cooney A, Lan Z . Orphan nuclear receptor function in the ovary. Front Biosci. 2007; 12:3398-405. DOI: 10.2741/2321. View

Jeyasuria P, Ikeda Y, Jamin S, Zhao L, de Rooij D, Themmen A . Cell-specific knockout of steroidogenic factor 1 reveals its essential roles in gonadal function. Mol Endocrinol. 2004; 18(7):1610-9. DOI: 10.1210/me.2003-0404. View

Reuter A, Goji K, Bingham N, Matsuo M, Parker K . A novel mutation in the accessory DNA-binding domain of human steroidogenic factor 1 causes XY gonadal dysgenesis without adrenal insufficiency. Eur J Endocrinol. 2007; 157(2):233-8. DOI: 10.1530/EJE-07-0113. View

Biason-Lauber A, Schoenle E . Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insufficiency. Am J Hum Genet. 2000; 67(6):1563-8. PMC: 1287931. DOI: 10.1086/316893. View

Hasegawa T, Fukami M, Sato N, Katsumata N, Sasaki G, Fukutani K . Testicular dysgenesis without adrenal insufficiency in a 46,XY patient with a heterozygous inactive mutation of steroidogenic factor-1. J Clin Endocrinol Metab. 2004; 89(12):5930-5. DOI: 10.1210/jc.2004-0935. View

Lacombe A, Lee H, Zahed L, Choucair M, Muller J, Nelson S . Disruption of POF1B binding to nonmuscle actin filaments is associated with premature ovarian failure. Am J Hum Genet. 2006; 79(1):113-9. PMC: 1474115. DOI: 10.1086/505406. View

Lavorgna G, Ueda H, Clos J, Wu C . FTZ-F1, a steroid hormone receptor-like protein implicated in the activation of fushi tarazu. Science. 1991; 252(5007):848-51. DOI: 10.1126/science.1709303. View

10.

Gurates B, Amsterdam A, Tamura M, Yang S, Zhou J, Fang Z . WT1 and DAX-1 regulate SF-1-mediated human P450arom gene expression in gonadal cells. Mol Cell Endocrinol. 2003; 208(1-2):61-75. DOI: 10.1016/s0303-7207(03)00198-9. View

11.

Luo X, Ikeda Y, Parker K . A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell. 1994; 77(4):481-90. DOI: 10.1016/0092-8674(94)90211-9. View

12.

Khajavi M, Inoue K, Lupski J . Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease. Eur J Hum Genet. 2006; 14(10):1074-81. DOI: 10.1038/sj.ejhg.5201649. View

13.

Shen W, Moore C, Ikeda Y, Parker K, Ingraham H . Nuclear receptor steroidogenic factor 1 regulates the müllerian inhibiting substance gene: a link to the sex determination cascade. Cell. 1994; 77(5):651-61. DOI: 10.1016/0092-8674(94)90050-7. View

14.

Luborsky J, Meyer P, Sowers M, Gold E, Santoro N . Premature menopause in a multi-ethnic population study of the menopause transition. Hum Reprod. 2003; 18(1):199-206. DOI: 10.1093/humrep/deg005. View

15.

Fogli A, Gauthier-Barichard F, Schiffmann R, Vanderhoof V, Bakalov V, Nelson L . Screening for known mutations in EIF2B genes in a large panel of patients with premature ovarian failure. BMC Womens Health. 2004; 4(1):8. PMC: 529454. DOI: 10.1186/1472-6874-4-8. View

16.

Achermann J, Ito M, Hindmarsh P, Jameson J . A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat Genet. 1999; 22(2):125-6. DOI: 10.1038/9629. View

17.

Nelson L . Clinical practice. Primary ovarian insufficiency. N Engl J Med. 2009; 360(6):606-14. PMC: 2762081. DOI: 10.1056/NEJMcp0808697. View

18.

Lin L, Philibert P, Ferraz-de-Souza B, Kelberman D, Homfray T, Albanese A . Heterozygous missense mutations in steroidogenic factor 1 (SF1/Ad4BP, NR5A1) are associated with 46,XY disorders of sex development with normal adrenal function. J Clin Endocrinol Metab. 2007; 92(3):991-9. PMC: 1872053. DOI: 10.1210/jc.2006-1672. View

19.

Mendelson C, Kamat A . Mechanisms in the regulation of aromatase in developing ovary and placenta. J Steroid Biochem Mol Biol. 2007; 106(1-5):62-70. PMC: 2075360. DOI: 10.1016/j.jsbmb.2007.05.001. View

20.

Achermann J, Ozisik G, Ito M, Orun U, Harmanci K, Gurakan B . Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic factor-1, in a dose-dependent manner. J Clin Endocrinol Metab. 2002; 87(4):1829-33. DOI: 10.1210/jcem.87.4.8376. View